Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
0.3929
+0.0059 (1.52%)
At close: Jan 8, 2026, 4:00 PM EST
0.4002
+0.0073 (1.86%)
After-hours: Jan 8, 2026, 7:41 PM EST
CUE's stock price has decreased by -75.44% in the past year and price targets may not have had time to catch up.
Cue Biopharma Analyst Ratings
Total Analysts
2
Consensus Rating
Strong Buy
Price Target
$3.00
Upside
+663.55%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| LUCID CAPITAL MARKETS | LUCID CAPITAL MARKETS | Strong Buy Initiates $4 | Strong Buy | Initiates | $4 | +918.07% | Aug 25, 2025 |
| Citizens Capital Markets | Citizens Capital Markets | Buy Reiterates $2 | Buy | Reiterates | $2 | +409.04% | Apr 2, 2025 |
| Stifel | Stifel | Strong Buy Maintains $8 → $4 | Strong Buy | Maintains | $8 → $4 | +918.07% | Aug 20, 2024 |
| JMP Securities | JMP Securities | Buy Maintains $15 → $2 | Buy | Maintains | $15 → $2 | +409.04% | Jul 26, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $8 → $3 | Buy | Maintains | $8 → $3 | +663.55% | Jul 26, 2024 |
| Stifel | Stifel | Strong Buy Maintains $8 | Strong Buy | Maintains | $8 | +1,936.14% | Apr 9, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $10 | Buy | Maintains | $10 | +2,445.18% | Apr 9, 2024 |
| Piper Sandler | Piper Sandler | Buy Reiterates $8 | Buy | Reiterates | $8 | +1,936.14% | Apr 3, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +1,427.11% | Mar 13, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $7 → $8 | Buy | Maintains | $7 → $8 | +1,936.14% | Nov 6, 2023 |
| Oppenheimer | Oppenheimer | Buy Initiates $10 | Buy | Initiates | $10 | +2,445.18% | Jun 26, 2023 |
| Stifel | Stifel | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +1,936.14% | Jun 15, 2023 |
| JMP Securities | JMP Securities | Buy Reiterates $15 | Buy | Reiterates | $15 | +3,717.77% | May 15, 2023 |
| Stifel | Stifel | Strong Buy Maintains $9 → $8 | Strong Buy | Maintains | $9 → $8 | +1,936.14% | Mar 22, 2023 |
| Oppenheimer | Oppenheimer | Buy Reiterates $10 | Buy | Reiterates | $10 | +2,445.18% | Mar 22, 2023 |
| Piper Sandler | Piper Sandler | Buy Initiates $7 | Buy | Initiates | $7 | +1,681.62% | Nov 21, 2022 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.